ZIM LABORATORIES Fact Sheet, ZIM LABORATORIES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES Fact Sheet    (ZIML)


Check Out: Why Millions of Dollars are Getting Pumped into this Sector?


Here is the latest financial fact sheet of ZIM LABORATORIES. For more details, see the ZIM LABORATORIES quarterly results and ZIM LABORATORIES share price and chart. For a sector overview, read our pharmaceuticals sector report.

ZIM LABORATORIES Price History

Price Rs 147.1
Mkt Cap Rs m 2,388
Vol '000 2.3
P/E X 38.0
P/CF X 10.3
EPS (TTM) Rs 3.9
1 Day % -1.8
No. of shares m 16.24
1 Week % -8.1
1 Month % 22.4
1 Year % 73.0
52 week H/L Rs 189.5/68.6
As on Jan 25, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ZIM LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ZIM LABORATORIES EQUITY SHARE DATA
High RsNANA480149131 
Low RsNANA1174253 
Sales per share (Unadj.) Rs285.3336.6208.0171.7189.2 
Earnings per share (Unadj.) Rs23.123.79.52.04.5 
Diluted earnings per shareRs11.411.89.42.04.5 
Cash flow per share (Unadj.) Rs34.435.916.610.914.2 
Dividends per share (Unadj.) Rs01.000.5000 
Adj. dividends per shareRs0.000.500.500.000.00 
Avg Dividend yield %NMNM0.200 
Book value per share (Unadj.) Rs146.5168.893.094.899.0 
Adj. book value per shareRs72.483.792.394.599.0 
Shares outstanding (eoy) m8.038.0616.1216.1816.24 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x001.40.60.5 
Avg P/E ratio x0031.446.920.5 
P/CF ratio (eoy) x0018.08.76.5 
Price / Book Value ratio x003.21.00.9 
Dividend payout %04.25.300 
Avg Mkt Cap Rs m004,8141,5441,497 
No. of employees `000NANANANANA 
Total wages/salary Rs m330408483353358 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ZIM LABORATORIES INCOME DATA
Net Sales Rs m2,2912,7133,3542,7773,073 
Other income Rs m5534204523 
Total revenues Rs m2,3462,7483,3742,8233,096 
Gross profit Rs m315406420226346 
Depreciation Rs m9098114144158 
Interest Rs m10593106127109 
Profit before tax Rs m1752492211102 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-115867-3229 
Profit after tax Rs m1861911533373 
Gross profit margin %13.715.012.58.111.3 
Effective tax rate %-6.223.430.5-4,678.328.5 
Net profit margin %8.17.04.61.22.4 
ZIM LABORATORIES BALANCE SHEET DATA
Current assets Rs m1,5381,7291,9531,8201,918 
Current liabilities Rs m1,1321,4141,5641,4341,420 
Net working cap to sales %17.711.611.613.916.2 
Current ratio x1.41.21.21.31.4 
Inventory Days Days526141616 
Debtors Days Days141120101893858 
Net fixed assets Rs m9591,2171,3241,3791,304 
Share capital Rs m8081161162162 
"Free" reserves Rs m1,0961,2801,3381,3731,445 
Net worth Rs m1,1761,3601,4991,5351,608 
Long term debt Rs m275203222274218 
Total assets Rs m2,4962,9463,2773,2003,222 
Interest coverage x2.73.73.11.01.9 
Debt to equity ratio x0.20.10.10.20.1 
Sales to assets ratio x0.90.91.00.91.0 
Return on assets %11.69.77.95.05.7 
Return on equity %15.814.110.22.14.6 
Return on capital %19.321.919.07.011.6 
Exports to sales %53.7062.057.667.4 
Imports to sales %6.3010.34.64.1 
Exports (fob) Rs m1,23102,0791,6002,072 
Imports (cif) Rs m1440345128127 
Fx inflow Rs m1,23202,0791,6972,140 
Fx outflow Rs m3220345128127 
Net fx Rs m91001,7341,5692,012 
ZIM LABORATORIES CASH FLOW
From Operations Rs m 321 367 349 219 319 
From Investments Rs m -72 -258 -207 -194 -59 
From Financial Activity Rs m -251 -98 -152 -22 -260 
Net Cashflow Rs m -3 10 -10 10 -1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 33.3%
Institution 0.0%
Non-Institution 66.7%
Total 100.0%
Free Float 66.7%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021
 

Company Information

Regd Off Sadoday Gyan (Ground Floor) Opp. Nadt, Nelson Square, Nagpur - 440013
E-mail infa@zimlab.in Web www.zimlab.in
Tel 0712-2588070 Fax
Sector PHARMACEUTICALS Group MNC
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1984 BSE CODE: 541400 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare ZIM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist (Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES - TEVA PHARMA COMPARISON

COMPARE ZIM LABORATORIES WITH

MARKET STATS